GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...
Americans with asthma and 16 million Americans with COPD need inhalers to breathe. Vermont Business Magazine Sen. Bernie Sanders (I-Vermont), Chairman of the Senate Com ...
The drugmaker's chief executive, Emma Walmsley noted this is the eighth time that GSK had headed the list, and comes after it pledged £1 billion ($1.2 billion) over the next decade to accelerate ...